Kayexalate is a potentially harmful therapy to treat hyperkalemia, it has a slow onset action (if at all) and doubtful efficacy. It also carries risk of life threatening gastrointestinal complications. There is NO CONVINCING EVIDENCE that Kayexalate increases fecal potassium losses.
